Publication | Closed Access

Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells

OncologyOncogenic AgentMedicineApoptosisCell DeathAnti-cancer AgentDna Damage ResponseNew Imidazopyridine DerivativeLung Cancer CellsPharmacologyCell BiologyTumor Microenvironment